Posted on 24/12/2009 in Marketing Services Caudex Medical is offering to help pharmaceutical companies get to grips with the updated guidelines for Good Publication Practice (GPP2).
Having been a participant in the revision process, the company now hopes to support its clients in understanding the implications of the new guidance.
The firm's commitment to spreading the word about GPP2, which was published by the BMJ earlier this year, includes the development of an "interactive training workshop" to inform clients about the changes.
In addition, Caudex has created "client-ready templates" for documentation in accordance with the requirements of GPP2.
"Always at the forefront of development in the world of medical communications, we have considered the implications of what the new guidance will mean in practice," the firm's website states.
First published in 2003, the Good Publication Practice guidelines were drawn up in an effort to ensure that the results of all clinical trials sponsored by pharmaceutical firms are presented in a responsible manner.
Other news stories from 24/12/2009
Read more in the Zenopa News Archive
How this news is generated
|
